|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Kindred Biosciences (NASDAQ: KIN) through any online brokerage.
The latest price target for Kindred Biosciences (NASDAQ: KIN) was reported by Lake Street on June 17, 2021. The analyst firm set a price target for 9.25 expecting KIN to rise to within 12 months (a possible 0.65% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Kindred Biosciences (NASDAQ: KIN) is $9.19 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kindred Biosciences.
There is no upcoming split for Kindred Biosciences.
Kindred Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.